Principal Securities’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.01M Buy
19,357
+394
+2% +$135K 0.08% 211
2026
Q1
$6.67M Buy
18,963
+1,298
+7% +$463K 0.1% 193
2025
Q4
$5.78M Buy
17,665
+1,246
+8% +$395K 0.09% 213
2025
Q3
$4.63M Buy
16,419
+406
+3% +$118K 0.08% 245
2025
Q2
$4.47M Buy
16,013
+2,401
+18% +$680K 0.08% 234
2025
Q1
$3.55M Hold
13,612
0.08% 241
2024
Q4
$3.55M Buy
13,612
+111
+0.8% +$32.9K 0.08% 241
2024
Q3
$4.35M Buy
13,501
+1,104
+9% +$361K 0.11% 186
2024
Q2
$3.87M Buy
12,397
+1,854
+18% +$545K 0.11% 176
2024
Q1
$3M Buy
10,543
+593
+6% +$174K 0.09% 205
2023
Q4
$2.87M Buy
+9,950
New +$2.71M 0.11% 181

Other funds holding AMGN

Principal Securities's AMGN Position: Q2 2026 in Review

Principal Securities increased its Amgen (AMGN) stake by 2.1% in Q2 2026, buying an estimated $135K and bringing the position to 19,357 shares worth $7.01M. The position accounts for 0.08% of the portfolio, ranked #211.

Principal Securities first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Principal Securities held 19,357 shares of Amgen worth $7.01M as of Q2 2026.
  • Principal Securities bought 394 Amgen shares in Q2 2026, an estimated $135K.
  • Amgen made up 0.08% of Principal Securities's portfolio in Q2 2026, its #211 holding.
  • Principal Securities first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Principal Securities's 13F filing for Q2 2026, filed 4 Aug 2026.